Harnessing Artificial Intelligence in the Battle Against Kawasaki Disease

By: Poojitha Nagishetti, Department of Computer Science & Engineering (Data Science), Student of Computer Science & Engineering, Madanapalle Institute of Technology and Science, Angallu(517325), Andhra Pradesh.

Abstract –

Kawasaki Disease is an acute self-limited febrile illness of childhood and is the second or third most common cause of acquired heart disease in children if the actual diagnosis is not entertained. It is feathery, inconsistent, and quite like other types of febrile diseases; the seriousness of these symptoms is one of its main defining characteristics. Based on emerging phenomenon in the recent years, AI emerges as the variable that brings novelty to the medical field particularly in diagnosing, treating and even management of various diseases inclusive of Kawasaki disease. The main concern of this article is to deliberate on the-valuable role of AI in combating the Kawasaki disease. The use of machine learning to perform the early prediction is also mentioned and the predictive decision-making to forecast the additional clinical evolution and possible complications regarding the certain disease and the patient’s background for conducting an individual prognosis of the treatment. Additionally, we underscore the efficiency of AI in the research process and specifically in the analysis of big data to understand the biomarkers’ contribution to the knowledge of KD. The efficacy of the employed AI methods in the clinical practice is illustrated by applying the cases and examples. Thus, it is crucial for continuing research in Kawasaki Disease’s treatment applying AI and strengthening the united work of clinician and the AI expert.

Keywords – Kawasaki Disease, Artificial Intelligence, Machine Learning, Early Detection, Personalized Treatment.

Introduction –

Kawasaki disease or KD is a rare systemic vasculitis disease that is primarily diagnosed in children going to school and especially those below the age of five. Initially described in 1967 by Dr. Tomisaku Kawasaki, this disease is caused by inflammation of blood vessels and can become life-threatening when affecting coronary arteries[1]. The exact cause of KD has not been fully elucidated, but it is believed that the disease follows an infectious agent in genetically susceptible persons.

The signs to look out for in a Kawasaki disease include fever for greater than five days, skin rash, red and swollen conjunctiva, red lips with cracks, strawberry red tongue, oedema of the hands and feet, and enlargement of lymph nodes. Many of these symptoms can mimic other febrile illnesses hence KD is often diagnosed only if one is very much aware of its existence. Early recognition is important because the disease can cause serious issues with the arteries and pumps of the heart, such as tears in the arteries that supply blood to the heart, inflammation in the heart muscle and damage to the heart valves.

For example, the course of Kawasaki disease is treated by administering intravenous immunoglobulin (IVIG) together with high-dose aspirin; both medicines are known to effectively reduce the possibility of the development of coronary artery lesions if given in the early stages of the illness. However, the patients may be at a risk of having persisted or recurrent of the coronary artery abnormalities and therefore requires monitoring for abnormality interventions.

Indeed, the diagnostic as well as therapeutic issues that surround Kawasaki disease are made even more complex by the relative rarity of the condition, as well as the polymorphic clinical manifestations of the disease. Historical practices involve clinical features and imaging examinations that take a long time as well as may have misleading assessments[2]. Also, the treatment and follow-up plan of KD need a long-term management because of several factors that dictate this condition and may not be inapplicable to each patient.

Here, it is necessary to go further into the details of how AI has been applied to meet the diagnostic and therapeutic difficulties presented by Kawasaki disease[3]. We also synthesize the role of AI tools in early detection, identification of students’ risk levels, development of tailor-made preventive interventions, and further investigations. Thus, discussing actual examples and focuses on the use of AI in managing Kawasaki diseases, we want to draw attention to how such practices can become revolutionary and continued developments and cooperation are necessary. Figure 1 describes the process from data collection to AI-driven decision making and patient care.

Clinical Presentation –Kawasaki disease typically presents with a constellation of symptoms, which may include Kawasaki disease arises with some symptoms and these may include:

• Fever: The essential Manifestation of KD is high temperate; more than 5 days in children.
• Rash: The skin condition can manifest itself in the form of rashes that are spread all over the body thus making the skin to appear peeled.
• Conjunctivitis: Given conjunctival injection – bilateral Conjunctival swab – no pus.
• Oral Changes: As for example presence of red and cracked lips, strawberry tongue, and erythema of the oral mucosa.
• Swollen Hands and Feet: Accumulation of fluids in the skin of hand and feet and rash with small vesicles on the skin.
• Lymphadenopathy: Enlarged lymph nodes particularly those which can be palpated around the neck.

Diagnostic Criteria –

Kawasaki disease is traditionally a clinical diagnosis and requires the measures set out by AHA to be used in diagnosing the disease. To meet the criteria for a definitive diagnosis, a patient typically must have: According to the guidelines, a patient requires the following to be diagnosed with APS:

• Fever, for at least five days.
• At least four of the following five principal clinical features: Presentation of at least four out of the five main clinical signs:

1. Rash

2. Conjunctivitis

3. Oral mucosal changes

4. Swollen hands and feet

5. Cervical lymphadenopathy

Therefore, if certain clinical manifestations are explicit, and the patient meets one or several of the criteria or has atypical symptoms, he/she can be diagnosed with KD.

Pathophysiology and Complications –

Kawasaki disease is an impact bearing on the inflammatory processes taking place in the body, in relation to which the disease may have severe outcomes associated with the cardiovascular system. The worst is ideally characterized by a potentially life-threatening clinical condition, which is connotated by the presence of coronary artery aneurysms, which may in the long run be triggered by inflamed arterial walls. Other conditions that relate with CV risks include myocarditis, pericarditis, valvular disorders, and other needed conditions.

AI in Kawasaki Disease –

AI has spread into most fields of medicine and offers innovative practices to identify and analyze complex patterns and incorporate them into efficient medical care mechanisms[4]. Therefore, Kawasaki disease (KD) where even diagnostic parameters tend to be quite difficult if assessed based on a single criterion, and where timely diagnosis and administration of treatment seem to be critical where the life of the patient can be at risk, should sooner embrace AI technologies than any other ailment. Here’s how AI is transforming the approach to Kawasaki disease[5]. This is how the use of AI impacts Kawasaki disease assessment and handling in particular:

1. Early Diagnosis and Detection:

• Machine Learning Models: This means that the AI algorithms the more so the machine learning models can analyze large patient data to arrive to patterns which could be associated with Kawasaki disease. As such models are trained from previous patients’ records, these models could be useful from the point of view of early detection of KD by analyzing small patterns in symptoms and laboratory examinations that indicate this disease.
• Natural Language Processing (NLP): Thus, this information that is stored in EHR in clinical notes, can be obtained applying NLP techniques. This can be utilized in possibly distinguishing other cases of Kawasaki disease by comparing symptoms known and the patient’s records.

2. Predictive Analytics:

• Risk Prediction Models: Considering the above findings, AI can be extended to come up with a model that predict the extent of dangerous condition such as CAAs. These models help in consideration of the patient or patient’s characteristics inclusive of demographic information, clinical manifestations, results of investigative procedures to make risk predictions on management plans.
• Progression Tracking: Using AI, the process of Kawasaki disease can be monitored in real time, while the potential further progression of the processes related to symptoms and laboratories can be predicted in advance. This assists the health care providers to do changes on the patient’s treatment plans early enough to better manage such patients.

3. Personalized Treatment:

• Treatment Optimization: It can be applied in the framework of prescribing individualized therapies making it easier for the doctors to consider the client characteristics and the result of therapies. For instance, AI shall determine the pattern and regimen by which IVIG and aspirin would be offered to the patient while avoiding choosing inherent facets of a patient.
• Tailored Follow-Up: which is equally true in the case of KD, AI can also be of help in defining the patient- specific measures in follow-up care and suggest how the observation of the patient’s state and treatment should be adapted depending on the patient’s risk factors and disease characteristics.

4. Enhancing Diagnostic Accuracy:

• Imaging Analysis: One of the subdivisions of AI that can be applied for interpreting medical pictures of any type is the deep learning, for example, echocardiogram for diagnostics of coronary artery disorders and various other complications that are associated with KD. It is most appropriate if these algorithms complement the diagnosis by highlighting incidences or changes on the monitors which might not be easily observed by the observers.
• Integration with Clinical Decision Support Systems: AI systems can be integrated in CDS to make and deliver the patient-specific advice and alert according to the latest information. This accumulates to knowledge in the clinician’s decisions and reduces the possibilities of misdiagnosis being made.

Table 1: Patient Outcomes: Before and After AI Implementation

Metric	Before AI Implementation	After AI Implementation
Accuracy of Diagnosis	Variable, dependent on clinician experience	Higher, consistent due to machine learning models
Time to Diagnosis	Often delayed due to manual analysis	Significantly reduced due to automated detection
Incidence of Severe Complications	Higher due to delayed diagnosis	Lower due to early detection and intervention
Treatment Personalization	Limited, based on standard protocols	High, based on AI-driven insights
Follow-Up Efficiency	Periodic, manual reviews	Continuous, automated monitoring

Future Directions –

Therefore, it is possible to hope for the further advancement of Al in the treatment of Kawasaki disease given the current technological and getting advancements[6]. Thanks to the recent developments in the field of AI, the algorithms’ diagnostic as well as disease prognosis ability is expected to be even more accurate. The wearable monitoring devices could be accompanied by AI for real-time information of the disease’s progression or any changes in the response to treatment consequently enhancing the prognosis and interferences[7]. Moreover, within the framework of new large and standardized datasets, the models that are required for training will be improved, therefore becoming more general and applicable to real-world conditions. As for the problems like data protection and patients’ data integration into the practice, it is necessary to establish closer collaboration between the healthcare institutions, academics, and companies developing AI technologies[8]. By continuing cooperation with other departments and by paying attention to the opportunities of creating AI solutions, it will be possible to learn novel approaches to the identification of KD earlier, the definition of the individual treatment plan, as well as the optimization of the outcomes of the existing therapy for the disease.

Conclusion –

As is well known, Kawasaki diseases is one of those diseases which make further difficulties in diagnosing and treating, because it relates to all the symptoms which belong to many other febrile illnesses and possible severe cardiac involvement. It is possible to solve these issues with the help of artificial intelligence (AI) applied to the sphere of health. Therefore, applying AI with the help of machine learning and deep learning algorithms, diagnosis in the early stage of a disease, prognosis and the choice of the treatment strategy contribute to the growth of the efficiency of the further treatment processes.

Because of the capability shown by the AI in handling large amount of data, it can have early recognition of the early signs of KD, which will mean that the risk of complications due to the same reason will be reduced. Specific therapeutic as well as surgical interventions indicated by AI are viable to raise the probability of the various treatment regimens regarding the various types of patients in existence are achievable. Additionally, wherever AI is utilized in research, enhanced biomarkers are discovered, and extensive knowledge and understanding of the diseases are obtained; hence, management and control of KD are improved.

In conclusion, it is crucial to acknowledge the role of AI as the uniquely beneficial tool for the definition and the management of Kawasaki disease so as to introduce the need for the further enhancement of the accuracy of the diagnosis, efficiency of the treatment, and the enhancement of the patient’s quality of life. More research and collaborations could increase the potential of the application of AI in addressing the condition and improve the lives for children with the said condition to a greater extent.

References –

1. N. R. de M. Alves, C. M. R. de Magalhães, R. de F. R. Almeida, R. C. R. dos Santos, L. Gandolfi, and R. Pratesi, “Prospective study of Kawasaki disease complications: review of 115 cases,” Rev. Assoc. Médica Bras. Engl. Ed., vol. 57, no. 3, pp. 295–300, May 2011, doi: 10.1016/S2255-4823(11)70062-5.
2. L. Triyono, R. Gernowo, P. Prayitno, M. Rahaman, and T. R. Yudantoro, “Fake News Detection in Indonesian Popular News Portal Using Machine Learning For Visual Impairment,” JOIV Int. J. Inform. Vis., vol. 7, no. 3, pp. 726–732, Sep. 2023, doi: 10.30630/joiv.7.3.1243.
3. Y. Pan and F.-Y. Jiao, “Application of artificial intelligence in the diagnosis and treatment of Kawasaki disease,” World J. Clin. Cases, vol. 12, no. 23, pp. 5304–5307, Aug. 2024, doi: 10.12998/wjcc.v12.i23.5304.
4. M. A. Portman, C. A. Magaret, G. Barnes, C. Peters, A. Rao, and R. Rhyne, “An Artificial Intelligence Derived Blood Test to Diagnose Kawasaki Disease,” Hosp. Pediatr., vol. 13, no. 3, pp. 201–210, Feb. 2023, doi: 10.1542/hpeds.2022-006868.
5. P. Pappachan, Sreerakuvandana, and M. Rahaman, “Conceptualising the Role of Intellectual Property and Ethical Behaviour in Artificial Intelligence,” in Handbook of Research on AI and ML for Intelligent Machines and Systems, IGI Global, 2024, pp. 1–26. doi: 10.4018/978-1-6684-9999-3.ch001.
6. M. Moslehpour, W.-K. Wong, K. V. Pham, and C. K. Aulia, “Repurchase intention of Korean beauty products among Taiwanese consumers,” Asia Pac. J. Mark. Logist., vol. 29, no. 3, pp. 569–588, Jan. 2017, doi: 10.1108/APJML-06-2016-0106.
7. B. W. McCrindle and E. S. S. Tierney, “Acute Treatment for Kawasaki Disease: Challenges for Current and Future Therapies,” J. Pediatr., vol. 184, pp. 7–10, May 2017, doi: 10.1016/j.jpeds.2017.01.072.
8. R. Uehara and E. D. Belay, “Epidemiology of Kawasaki Disease in Asia, Europe, and the United States,” J. Epidemiol., vol. 22, no. 2, pp. 79–85, Mar. 2012, doi: 10.2188/jea.JE20110131.
9. Sarin, S., Singh, S. K., Kumar, S., Goyal, S., Gupta, B. B., Arya, V., & Chui, K. T. (2024). SEIR‐driven semantic integration framework: Internet of Things‐enhanced epidemiological surveillance in COVID‐19 outbreaks using recurrent neural networks. IET Cyber‐Physical Systems: Theory & Applications.
10. Chhabra, A., Singh, S. K., Sharma, A., Kumar, S., Gupta, B. B., Arya, V., & Chui, K. T. (2024). Sustainable and intelligent time-series models for epidemic disease forecasting and analysis. Sustainable Technology and Entrepreneurship, 3(2), 100064.

Cite As

Nagishetti P. (2024) Harnessing Artificial Intelligence in the Battle Against Kawasaki Disease, Insights2Techinfo, pp.1

745400cookie-checkHarnessing Artificial Intelligence in the Battle Against Kawasaki Diseaseyes